title: Tumor treating fields therapy for recurrent glioblastoma.
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D016543:Central Nervous System Neoplasms / Q000517:prevention & control / Q000628:therapy*; D003131:Combined Modality Therapy / Q000379:methods; D003362:Cost-Benefit Analysis; D005069:Evaluation Studies as Topic; D055317:Evidence-Based Practice; D005909:Glioblastoma / Q000628:therapy*; D006801:Humans; D007342:Insurance Benefits / Q000592:standards; D007348:Insurance, Health / Q000191:economics / Q000592:standards; D055909:Magnetic Field Therapy / Q000191:economics / Q000706:statistics & numerical data*; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D010166:Palliative Care; D016019:Survival Analysis; D017211:Treatment Failure
chemical_list: D000970:Antineoplastic Agents